Free Trial
Jeet Mukherjee

Jeet Mukherjee Analyst Performance

Vice President & Biotechnology Analyst at BTIG Research

Jeet Mukherjee is a stock analyst at BTIG Research in the medical sector, covering 3 publicly traded companies. Over the past year, Jeet Mukherjee has issued 5 stock ratings, including and buy recommendations. While full access to Jeet Mukherjee's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Jeet Mukherjee's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
5 Last 0 Years
Buy Recommendations
100.00% 5 Buy Ratings
Companies Covered
3 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy0.0%0 ratings
Buy100.0%5 ratings
Hold0.0%0 ratings
Sell0.0%0 ratings

the majority (100.0%) have been Buy recommendations.

Best & Worst Calls

This analyst does not have any ratings with enough history to determine best and worst calls.

Exchange Coverage

ExchangePercentageCount
NASDAQ
100.0% of companies on NASDAQ
3 companies

Jeet Mukherjee, an analyst at BTIG Research, currently covers 3 companies listed on , with the majority traded on NASDAQ.

Coverage Focus

Sector IconSectorPercentage
Medical
3 companies
100.0%

Jeet Mukherjee of BTIG Research specializes in stock coverage within the Medical sector.

Coverage Industries

IndustryPercentage
MED - BIOMED/GENE
3 companies
100.0%

About Jeet Mukherjee

Jeet Mukherjee, PhD, is a Vice President and Biotechnology Analyst at BTIG. Prior to joining BTIG, Mr. Mukherjee was a Senior Associate at Casdin Capital where he focused on public and private investments in the therapeutics space. Previously, he was a Senior Associate on the biotechnology equity research team at Jefferies. Mr. Mukherjee earned his PhD in pharmacology from Weill Cornell Medical College and his bachelor’s degree in biology from the University of Delaware.
Follow on LinkedIn

Jeet Mukherjee's Ratings History at BTIG Research

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
Monopar Therapeutics Inc. stock logo
MNPR
Monopar Therapeutics
9/25/2025Boost Price Target$73.04$104.00Buy
Arvinas, Inc. stock logo
ARVN
Arvinas
9/18/2025Lower Price Target$7.75$10.00Buy
Monopar Therapeutics Inc. stock logo
MNPR
Monopar Therapeutics
9/15/2025Reiterated Rating$48.51$87.00Buy
Monopar Therapeutics Inc. stock logo
MNPR
Monopar Therapeutics
9/9/2025Initiated Coverage$41.48$87.00Buy
Kymera Therapeutics, Inc. stock logo
KYMR
Kymera Therapeutics
6/26/2025Reiterated Rating$46.47$59.00Buy